Healius | HLS - Kreditur Perdagangan

Harga Saham

0.52

Perubahan Harian

0 0%

Bulanan

-3.74%

Tahunan

-64.60%

Q2 Perkiraan

0.52

Keuangan

AUD

AUD 3.07B

AUD 60.1M

Biaya Penjualan

AUD 218.7M

AUD 1.04B

Kewajiban Lancar

AUD 804.2M

AUD 1.4B

Dividen - Hasil

7.19

AUD 23.7M

AUD 74.9M

8K

Eps Laba Per Saham

AUD -0.04

Modal Dan Cadangan

AUD 1.03B

Laba Kotor Pada Penjualan

AUD 554.4M

Beban Bunga Utang

AUD 32.8M

AUD 1.22B

Kapitalisasi Pasar

AUD 373.94M

Batas Pemasukan

AUD -12.8M

Biaya Operasional

AUD 684.9M

Laba Operasional

AUD -22.6M

Modal Saham Biasa

AUD 2.6B

Pe Harga Untuk Laba

57.43

Laba Sebelum Pajak

AUD -19.2M

Pendapatan Penjualan

AUD 688.1M

Beban Penjualan Dan Administrasi

AUD 393.4M

AUD 31.9M

Kreditur Perdagangan

AUD 133.9M

Debitur Perdagangan

AUD 144.6M

	Kreditur Perdagangan	Perubahan		Tanggal
Alcidion	AUD 5.89M		3.62M	2025-12
Ansell	USD 302.3M		51.4M	2025-12
Cochlear	AUD 281.3M		17.1M	2025-12
CSL	USD 3.17B		290M	2025-12
Fisher Paykel Healthcare	NZD 267.8M		4M	2025-12
Integral Diagnostics	AUD 28.28M		17.87M	2023-12
Mayne Pharma	AUD 30.25M		2.99M	2025-06
Nanosonics	AUD 12.22M		10.69M	2025-12
Polynovo	AUD 4.9M		2.04M	2025-12
Ramsay Health Care	AUD 2.02B		289.9M	2025-12
ResMed	USD 250.41M		16.36M	2025-12
Sigma Healthcare	AUD 1.32B		970.03M	2025-12
Sonic Healthcare	AUD 313.54M		543.93M	2024-06